Mass Spectrometry Assay for eIF4E Regulon Analysis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current diagnostic and analytical methods do not provide for enhanced detection, analysis, and therapeutic monitoring of the eukaryotic translation initiation factor eIF4E and its regulon activity, which is crucial for understanding its role in cellular growth and malignant transformation.

Innovation Solution

Development of highly sensitive, high-throughput mass spectrometry-based assays that enable single-sample multiplexed analysis of target proteins, including eIF4E and its regulon components, without the need for antibodies, allowing for the detection of eIF4E and its phosphorylation states.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If mass spectrometry is used for protein analysis, then measurement precision is improved, but sample processing complexity and time increase

Engineering Contradiction:
Improvedetection sensitivityVSAvoidsample processing time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent applies preliminary action by performing enrichment of target proteins and peptides before mass spectrometry analysis. This pre-processing step concentrates the analytes of interest, improving detection sensitivity while establishing a streamlined workflow that reduces overall processing time by eliminating the need for repeated enrichment steps.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent implements universality through a single sample preparation protocol that simultaneously enriches multiple target proteins and peptides. This multi-functional approach allows concurrent analysis of various eIF4E-related proteins and their phosphorylation states, reducing total analysis time while maintaining high measurement precision across multiple targets.

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Measurement precision

If antibody-based enrichment is used, then target protein detection is improved, but assay development time increases

Engineering Contradiction:
Improvetarget detection capabilityVSAvoidassay setup time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent employs disposable, non-antibody enrichment materials such as immobilized metal affinity chromatography (IMAC) resins or other affinity matrices that can be rapidly prepared and discarded. These replace expensive, time-consuming antibody reagents with simpler, shorter-lived enrichment media that eliminate months of antibody generation and validation while maintaining effective target protein enrichment.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The patent applies parameter changes by modifying the enrichment approach from antibody-based specific binding to alternative mechanisms such as metal-chelate affinity, charge-based interactions, or other physicochemical properties. This fundamental parameter change in the enrichment mechanism dramatically reduces assay setup time while preserving the ability to selectively detect target proteins with high precision.

Inventive Principle:
Principle #35Parameter changes

3Measurement precision

If multiple target proteins are analyzed separately, then measurement precision is maintained, but productivity decreases

Engineering Contradiction:
Improvequantification accuracyVSAvoidthroughput
Core Design Contradiction:
Measurement precisionVSProductivity

Solution Approach 1:

The patent merges the analysis of multiple target proteins into a single mass spectrometry run. By using targeted mass spectrometry methods such as multiple reaction monitoring (MRM) or parallel reaction monitoring (PRM), the system simultaneously quantifies multiple eIF4E-related proteins and their phosphorylation forms in one experiment, maintaining high measurement precision while dramatically increasing productivity compared to separate analyses.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The patent implements universality through a single analytical platform that handles multiple targets concurrently. The mass spectrometry method is designed to detect and quantify various proteins and their modified forms (such as phosphorylated states) in the same sample, providing multi-functional analysis capability that maintains quantification accuracy across all targets while maximizing throughput.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

These assays provide a robust and efficient means to analyze eIF4E and its regulon activity, facilitating the identification, diagnosis, and monitoring of eIF4E-related processes, and the discovery of agents that modulate its activity, thereby aiding in cancer diagnosis and treatment.

Implementation Method 1

Mass spectrometry (MS) is well established as a robust assay platform for small molecules

Methodology Applied
Scientific EffectMass spectrometry:

Implementation Method 2

the need for extensive sample processing for most target peptides and proteins

Methodology Applied
Scientific EffectIonization: Ionisation

Data Source

PatentUS9110074B2Mass spectrometry assay for <i>eIF4E </i>and <i>eIF4E </i>regulon activity
Publication Date: 2015.08.18 TRANSLATIONAL THERAPEUTICS INC
  • US9110074B2 patent drawing
  • US9110074B2 patent drawing
  • US9110074B2 patent drawing

AI summary

Provided is a highly sensitive high throughput mass spectrometry-based quantitative assay for 4E/4E regulon pathway proteins has been developed which provides for single sample multiplexed analysis, as well as the analysis of protein phosphorylation states. It may be adapted for use as the first single sample analytical method of the 4E/4E regulon biological pathway.